Skip to main content

Advertisement

Log in

Prognosis of synchronous bilateral breast cancer: a review and meta-analysis of observational studies

  • Review
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Currently, no consistent evidence-based guidelines for the management of synchronous bilateral breast cancer (SBBC) exist and it is uncertain how presenting with SBBC affects patients’ prognosis. We conducted a review of studies analyzing the association between SBBC and prognosis. The studies that reported adjusted effect measures were included in meta-analyses of effect of bilaterality on breast cancer mortality. From 57 initially identified records 17 studies from 11 different countries including 8,050 SBBC patients were included. The quality of the studies varied but was generally low with small sample sizes, and lack of consistent, detailed histo-pathological information. When doing meta-analysis on the subgroup of studies that provided adjusted effect estimates on breast cancer mortality (nine studies including 3,631 SBBC cases), we found that bilaterality in itself had a negative impact on prognosis after adjustment for known prognostic factors (pooled HR 1.37, 95 % CI 1.24–1.50, p < 0.0001). Multiple sensitivity analyses indicated robustness of the overall estimate. This review summarizes the current evidence of the association between SBBC and prognosis. The previously accepted convention that appropriate adjuvant treatment can be determined by considering the higher risk cancer was not confirmed in this review; rather it seems that being diagnosed with two tumors simultaneously entails a worse prognosis above and beyond that of the unilateral cancers of the same stage. To determine the true association between SBBC and breast cancer prognosis, studies of large and updated samples of SBBC should be done and include thorough histo-pathologic information.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Nichol AM, Yerushalmi R, Tyldesley S et al (2011) A case-match study comparing unilateral with synchronous bilateral breast cancer outcomes. J Clin Oncol 29(36):4763–4768

    Article  PubMed  Google Scholar 

  2. Verkooijen HM, Chatelain V, Fioretta G et al (2007) Survival after bilateral breast cancer: results from a population-based study. Breast Cancer Res Treat 105(3):347–357

    Article  PubMed  Google Scholar 

  3. Renz DM, Bottcher J, Baltzer PA et al (2010) The contralateral synchronous breast carcinoma: a comparison of histology, localization, and magnetic resonance imaging characteristics with the primary index cancer. Breast Cancer Res Treat 120(2):449–459

    Article  PubMed  Google Scholar 

  4. Irvine T, Allen DS, Gillett C, Hamed H, Fentiman IS (2009) Prognosis of synchronous bilateral breast cancer. Br J Surg 96(4):376–380

    Article  CAS  PubMed  Google Scholar 

  5. Hartman M, Czene K, Reilly M et al (2005) Genetic implications of bilateral breast cancer: a population based cohort study. Lancet Oncol 6(6):377–382

    Article  PubMed  Google Scholar 

  6. Imyanitov EN, Cornelisse CJ, Devilee P (2007) Searching for susceptibility alleles: emphasis on bilateral breast cancer. Int J Cancer 121(4):921–923

    Article  CAS  PubMed  Google Scholar 

  7. Antoniou AC, Easton DF (2003) Polygenic inheritance of breast cancer: implications for design of association studies. Genet Epidemiol 25:190–192

    Article  PubMed  Google Scholar 

  8. Hartman M, Czene K, Reilly M et al (2007) Incidence and prognosis of synchronous and metachronous bilateral breast cancer. J Clin Oncol 25(27):4210–4216

    Article  PubMed  Google Scholar 

  9. Quan G, Pommier SJ, Pommier RF (2008) Incidence and outcomes of contralateral breast cancers. Am J Surg 195(5):645–650

    Article  PubMed  Google Scholar 

  10. Schwentner L, Wolters R, Wischnewsky M, Kreienberg R, Wockel A (2012) Survival of patients with bilateral versus unilateral breast cancer and impact of guideline adherent adjuvant treatment: a multi-centre cohort study of 5292 patients. Breast 21(2):171–177

    Article  PubMed  Google Scholar 

  11. Jobsen JJ, van der Palen J, Ong F, Meerwaldt JH (2003) Synchronous, bilateral breast cancer: prognostic value and incidence. Breast 12(2):83–88

    Article  CAS  PubMed  Google Scholar 

  12. Polednak AP (2003) Bilateral synchronous breast cancer: a population-based study of characteristics, method of detection, and survival. Surgery 133(4):383–389

    Article  PubMed  Google Scholar 

  13. McCaul K (2006) Bilateral breast cancer incidence and survival, Thesis (PhD). School of Population Health and Clinical Practice, University of Adelaide. http://hdl.handle.net/2440/37870. Accessed 13 Dec 2013

  14. Beckmann KR, Buckingham J, Craft P et al (2011) Clinical characteristics and outcomes of bilateral breast cancer in an Australian cohort. Breast 20(2):158–164

    Article  CAS  PubMed  Google Scholar 

  15. Shi YX, Xia Q, Peng RJ et al (2012) Comparison of clinicopathological characteristics and prognoses between bilateral and unilateral breast cancer. J Cancer Res Clin Oncol 138(4):705–714

    Article  PubMed  Google Scholar 

  16. Roder D, de Silva P, Zorbas H et al (2012) Survival from synchronous bilateral breast cancer: the experience of surgeons participating in the breast audit of the Society of Breast Surgeons of Australia and New Zealand. Asian Pac J Cancer Prev 13(4):1413–1418

    Article  PubMed  Google Scholar 

  17. Gollamudi SV, Gelman RS, Peiro G et al (1997) Breast-conserving therapy for stage I–II synchronous bilateral breast carcinoma. Cancer 79(7):1362–1369

    Article  CAS  PubMed  Google Scholar 

  18. Schmid SM, Pfefferkorn C, Myrick ME et al (2011) Prognosis of early-stage synchronous bilateral invasive breast cancer. Eur J Surg Oncol 37(7):623–628

    Article  CAS  PubMed  Google Scholar 

  19. de la Rochefordiere A, Asselain B, Scholl S et al (1994) Simultaneous bilateral breast carcinomas: a retrospective review of 149 cases. Int J Radiat Oncol Biol Phys 30(1):35–41

    Article  PubMed  Google Scholar 

  20. Higgins J, Thompson S, Deeks J, Altman D (2002) Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice. J Health Serv Res Policy 7(1):51–61

    Article  PubMed  Google Scholar 

  21. Diaz R, Munarriz B, Santaballa A, Palomar L, Montalar J (2012) Synchronous and metachronous bilateral breast cancer: a long-term single-institution experience. Med Oncol 29(1):16–24

    Article  PubMed  Google Scholar 

  22. Hungness ES, Safa M, Shaughnessy EA et al (2000) Bilateral synchronous breast cancer: mode of detection and comparison of histologic features between the 2 breasts. Surgery 128(4):702–707

    Article  CAS  PubMed  Google Scholar 

  23. Beinart G, Gonzalez-Angulo AM, Broglio K et al (2007) Clinical course of 771 patients with bilateral breast cancer: characteristics associated with overall and recurrence-free survival. Clin Breast Cancer 7(11):867–874

    Article  PubMed  Google Scholar 

  24. Kollias J, Ellis IO, Elston CW, Blamey RW (2001) Prognostic significance of synchronous and metachronous bilateral breast cancer. World J Surg 25(9):1117–1124

    Article  CAS  PubMed  Google Scholar 

  25. Sobin LH, Gospodarowicz MK, Wittekind C (2013) International Union Against Cancer (UICC) TNM Classification of Malignant Tumors, 7th edn. Wiley-Blackwell, Oxford

    Google Scholar 

  26. Kwast AB, Liu L, Roukema JA et al (2012) Increased risks of third primary cancers of non-breast origin among women with bilateral breast cancer. Br J Cancer 107(3):549–555

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  27. Imyanitov EN, Hanson KP (2003) Molecular pathogenesis of bilateral breast cancer. Cancer Lett 191(1):1–7

    Article  CAS  PubMed  Google Scholar 

  28. Iyevleva AG, Kuligina ES, Mitiushkina NV, Togo AV, Miki Y, Imyanitov EN (2012) High level of miR-21, miR-10b, and miR-31 expression in bilateral vs. unilateral breast carcinomas. Breast Cancer Res Treat 131(3):1049–1059

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Timothy SH Mak (PhD) for statistical assistance and valuable comments in preparation of the manuscript.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marianne Holm.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Holm, M., Tjønneland, A., Balslev, E. et al. Prognosis of synchronous bilateral breast cancer: a review and meta-analysis of observational studies. Breast Cancer Res Treat 146, 461–475 (2014). https://doi.org/10.1007/s10549-014-3045-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-014-3045-0

Keywords

Navigation